Maleki-Kakelar Hadi, Dehghani Jaber, Barzegari Abolfazl, Barar Jaleh, Shirmohamadi Masoud, Sadeghi Javid, Omidi Yadollah
Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Bioimpacts. 2020;10(2):65-72. doi: 10.34172/bi.2020.09. Epub 2019 Jun 28.
Gastric cancer is considered the second prevalent cause of death around the world. This type of cancer is generally induced by which could colonize within the gastric mucosa of the infected cases. To date, triple antibiotic therapy has routinely been utilized for controlling the induced infection. However, this strategy has been unsuccessful, in large part because of issues such as occurring point mutations in the genome that can induce resistance to the antibiotics administered. Recently, it has been shown that different probiotics may have strong anti-cancer effects, in which they are capable of inhibiting by both immunological and non-immunological mechanisms. Here, we aimed at finding possible anti-cancer impacts of the probiotic bacterium on gastric cancer, AGS cells. The anti-cancer effects of the conditioned media of the locally isolated on the AGS cells were evaluated by different analyses such as flow cytometry, DNA ladder assay, DAPI staining, and RT-PCR. Our findings showed that the conditioned media of can inhibit both and AGS cells through up-/down-regulation of PTEN, Bax, TLR4, and AKT genes. The exudates of the probiotic bacteria can increase the expression of PTEN, Bax, and TLR4, and also decrease the expression of AKT gene. In agreement with different reports, our results proved the anti-cancer effects of the locally isolated through some immunological cell signaling pathways. Accordingly, it seems the probiotics could be considered as at least a complementary treatment for different types of malignancies.
胃癌被认为是全球第二大常见死因。这种癌症通常由能够在感染病例的胃黏膜中定植的[某种因素]诱发。迄今为止,三联抗生素疗法一直被常规用于控制[该因素]引发的感染。然而,这一策略并不成功,很大程度上是因为诸如[某种因素]基因组中出现点突变从而对抗生素产生耐药性等问题。最近,研究表明不同的益生菌可能具有强大的抗癌作用,它们能够通过免疫和非免疫机制抑制[某种因素]。在此,我们旨在探究益生菌[某种细菌名称]对胃癌AGS细胞可能产生的抗癌影响。通过流式细胞术、DNA梯状条带分析、DAPI染色和逆转录聚合酶链反应等不同分析方法,评估了本地分离的[某种细菌名称]的条件培养基对AGS细胞的抗癌作用。我们的研究结果表明,[某种细菌名称]的条件培养基可通过上调/下调PTEN、Bax、TLR4和AKT基因来抑制[某种因素]和AGS细胞。益生菌[某种细菌名称]的分泌物可增加PTEN、Bax和TLR4的表达,同时降低AKT基因的表达。与不同的报道一致,我们的结果通过一些免疫细胞信号通路证明了本地分离的[某种细菌名称]的抗癌作用。因此,似乎益生菌至少可以被视为不同类型恶性肿瘤的一种辅助治疗方法。